Cassaday & Co Wealth Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199K Sell
1,922
-7
-0.4% -$625 ﹤0.01% 356
2026
Q1
$139K Buy
+1,929
New +$149K ﹤0.01% 391
2024
Q4
Sell
-5,146
Closed -$324K 322
2024
Q3
$324K Sell
5,146
-342
-6% -$20K 0.01% 229
2024
Q2
$324K Buy
5,488
+107
+2% +$6.69K 0.01% 218
2024
Q1
$429K Sell
5,381
-351
-6% -$26.8K 0.01% 183
2023
Q4
$453K Sell
5,732
-442
-7% -$31.5K 0.02% 168
2023
Q3
$431K Buy
6,174
+725
+13% +$51.4K 0.02% 162
2023
Q2
$377K Sell
5,449
-873
-14% -$62.1K 0.01% 176
2023
Q1
$470K Buy
6,322
+101
+2% +$8.47K 0.02% 158
2022
Q4
$580K Buy
+6,221
New +$600K 0.03% 139

Other funds holding CVS

Cassaday & Co Wealth Management's CVS Position: Q2 2026 in Review

Cassaday & Co Wealth Management reduced its CVS Health (CVS) stake by 0.36% in Q2 2026, selling an estimated $625 and leaving 1,922 shares worth $199K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Cassaday & Co Wealth Management first reported a position in CVS in Q4 2022 and has held it in 10 quarters since. The position peaked at $580K in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Cassaday & Co Wealth Management held 1,922 shares of CVS Health worth $199K as of Q2 2026.
  • Cassaday & Co Wealth Management sold 7 CVS Health shares in Q2 2026, an estimated $625.
  • CVS Health made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #356 holding.
  • Cassaday & Co Wealth Management first reported a position in CVS Health in Q4 2022 and has held it in 10 quarters since.
  • Cassaday & Co Wealth Management's CVS Health position peaked at $580K in Q4 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.